Theriva Biologics Reports $18.3M In Cash For Q1 2024, Which Is Expected To Provide Runway Into The First Quarter Of 2025
Theriva Biologics Reports $18.3M In Cash For Q1 2024, Which Is Expected To Provide Runway Into The First Quarter Of 2025
Theriva Biologics報告稱,2024年第一季度有1830萬美元的現金,預計將爲2025年第一季度提供資金
Theriva Biologics Reports $18.3M In Cash For Q1 2024, Which Is Expected To Provide Runway Into The First Quarter Of 2025
Theriva Biologics報告稱,2024年第一季度有1830萬美元的現金,預計將爲2025年第一季度提供資金
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。